The association between statins and gait speed reserve in older adults: effects of concomitant medication
Authors:
Open Access
- 7 May 2025
- journal article
- research article
- Published by Springer Nature in GeroScience
- Vol. 48 (1) , 777-792
Abstract
Statins are frequently prescribed to older adults, yet their effects on ageing phenotypes such as frailty or physiological reserves remain poorly understood. Gait Speed Reserve (GSR), defined as the difference between maximal and usual gait speeds, serves as an indicator of physiological reserve, reflecting the body’s ability to perform beyond baseline functional levels. Polypharmacy, prevalent in this population, may contribute to inconsistent findings through interactions between statins and concomitant medications. We aimed to investigate how concomitant medications moderate the association between statin use and GSR in older adults. To this end, we conducted a cross-sectional observational cohort study using data from the Mobility Center at the University Department of Geriatric Medicine FELIX PLATTER, Basel, Switzerland ( n = 5519 adults aged ≥ 60 years). Moderation regression analyses with propensity score weighting were used to evaluate the effect of concomitant medications on the association between statin use and GSR. Results showed statin use was associated with a lower GSR compared to non-use (− 1.9 cm/s [95% CI, − 3.1 to − 0.72]). However, ACE inhibitors and aspirin significantly influenced this association. The GSR difference for statin users compared to non-users increased by 3.7 cm/s (from − 2.2 to 1.5 cm/s; 95% CI, 0.0 to 7.4) with concomitant ACE inhibitor use and by 5.8 cm/s (from − 3.4 to 2.3 cm/s; 95% CI, 2.5 to 9.1) with aspirin use. We found no statistically significant association between statin use and usual gait speed, the secondary outcome. In conclusion, ACE inhibitors and aspirin interacted with statins, reversing the negative association with GSR into a positive one when co-used. Future clinical trials are needed to determine causality and further investigate the impact of concomitant medication use on statin effects in aging populations. Meanwhile, our findings underscore the importance of considering concomitant medication use when assessing the effects of statins in older adults.Keywords
Funding Information
- Universitair Ziekenhuis Gent
- University of Basel
This publication has 60 references indexed in Scilit:
- Gait Speed Reserve in the general population-based ‘Good Aging in Skåne’ cohort study—distribution and associated factorsGeroScience, 2024
- Fall-Risk-Increasing Drugs and Gait Performance in Community-Dwelling Older Adults: Exploratory Results from the Gait and Brain StudyDrugs & Aging, 2023
- Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older PeopleJAMA Internal Medicine, 2022
- Intrinsic Capacity as a Determinant of Physical Resilience in Older AdultsThe Journal of nutrition, health and aging, 2021
- Phenotypic frailty and multimorbidity are independent 18-year mortality risk indicators in older menEuropean Geriatric Medicine, 2021
- Drug Prescription in Older Swiss Men and Women Followed in Family MedicineDrugs - Real World Outcomes, 2019
- Cognitive status, fast walking speed and walking speed reserve—the Gait and Alzheimer Interactions Tracking (GAIT) studyGeroScience, 2017
- Biomarkers for physical frailty and sarcopenia: state of the science and future developmentsJournal of Cachexia, Sarcopenia and Muscle, 2015
- Is Statin Use Associated With New Joint‐Related Symptoms, Physical Function, and Quality of Life? Results From Two Population‐Based Cohorts of WomenArthritis Care & Research, 2014
- Guidelines for clinical applications of spatio-temporal gait analysis in older adultsAging Clinical and Experimental Research, 2006